↓ Skip to main content

Reassessing the NTCTCS Staging Systems for Differentiated Thyroid Cancer, Including Age at Diagnosis

Overview of attention for article published in Thyroid, August 2015
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
19 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Reassessing the NTCTCS Staging Systems for Differentiated Thyroid Cancer, Including Age at Diagnosis
Published in
Thyroid, August 2015
DOI 10.1089/thy.2015.0148
Pubmed ID
Authors

Donald S.A. McLeod, Jacqueline Jonklaas, James D. Brierley, Kenneth B. Ain, David S. Cooper, Henry G. Fein, Bryan R. Haugen, Paul W. Ladenson, James Magner, Douglas S. Ross, Monica C. Skarulis, David L. Steward, Mingzhao Xing, Danielle R. Litofsky, Harry R. Maxon, Steven I. Sherman

Abstract

Thyroid cancer is unique for having age as a staging variable. Recently, the commonly used age cut-point of 45 years has been questioned. We assessed alternate staging systems on the outcome of overall survival, and compared these with current National Thyroid Cancer Treatment Cooperative Study (NTCTCS) staging systems for papillary and follicular thyroid cancer. We assessed 4,721 patients with differentiated thyroid cancer. Five potential alternate staging systems were generated at age cut-points in 5-year increments from 35 to 70 years, and tested for model discrimination (Harrell's C-statistic) and calibration (R2). The best five models for papillary and follicular cancer were further tested with bootstrap resampling and significance testing for discrimination. The best five alternate papillary cancer systems had age cut-points of 45-50 years, with the highest scoring model using 50 years. No significant difference in C-statistic was found between the best alternate and current NTCTCS systems (p=0.200). The best five alternate follicular cancer systems had age cut-points of 50-55 years, with the highest scoring model using 50 years. All five best alternate staging systems performed better compared with the current system (p=0.003 to 0.035). There was no significant difference in discrimination between the best alternate system (cut-point age 50 years) and the best system of cut-point age 45 years (p=0.197). No alternate papillary cancer systems assessed were significantly better than the current system. New alternate staging systems for follicular cancer appear to be better than the current NTCTCS system, although they require external validation.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 19 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 37%
Other 3 16%
Student > Master 2 11%
Student > Doctoral Student 1 5%
Student > Ph. D. Student 1 5%
Other 3 16%
Unknown 2 11%
Readers by discipline Count As %
Medicine and Dentistry 8 42%
Agricultural and Biological Sciences 3 16%
Pharmacology, Toxicology and Pharmaceutical Science 2 11%
Psychology 2 11%
Nursing and Health Professions 1 5%
Other 0 0%
Unknown 3 16%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 July 2018.
All research outputs
#16,048,318
of 25,377,790 outputs
Outputs from Thyroid
#1,440
of 2,211 outputs
Outputs of similar age
#148,110
of 278,032 outputs
Outputs of similar age from Thyroid
#18
of 28 outputs
Altmetric has tracked 25,377,790 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,211 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.7. This one is in the 32nd percentile – i.e., 32% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 278,032 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 28 others from the same source and published within six weeks on either side of this one. This one is in the 35th percentile – i.e., 35% of its contemporaries scored the same or lower than it.